Results 201 to 210 of about 3,057,389 (302)
ABSTRACT Objective To explore the predictive value of blood routine parameters for surgical pathological complete response (PCR) following neoadjuvant immunotherapy combined with chemotherapy (NICC) in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC).
Yu‐Dong Ning +4 more
wiley +1 more source
The Role of Artificial Intelligence in Prognosis, Recurrence Prediction, and Treatment Outcomes in Laryngeal Cancer: A Systematic Review. [PDF]
Al-Hakami HA +10 more
europepmc +1 more source
ABSTRACT Objective To provide an overview of potential biases resulting from the utilization of artificial intelligence (AI) in otolaryngology and techniques to mitigate them. Data Sources Literature review and expert opinion. Conclusions AI promises to fundamentally transform medicine.
Matthew T. Ryan, David A. Gudis
wiley +1 more source
Artificial Intelligence in Laryngeal Cancer Management: Enhancing Guidelines or Redefining Standards? [PDF]
Dedivitis RA +5 more
europepmc +1 more source
ABSTRACT Objective To provide a comprehensive review of the current landscape of artificial intelligence (AI) applications in voice disorder, with emphasis on emerging applications, limitations, and future directions for clinical integration. Methods Literature review.
Rachel B. Kutler, Anaïs Rameau
wiley +1 more source
Summary of the best evidence for the prevention and management of postoperative tracheostomy complications in laryngeal cancer patients. [PDF]
Xing R +5 more
europepmc +1 more source
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan +2 more
wiley +1 more source
Depression Among Patients With Laryngeal Cancer: A Retrospective Cohort Study. [PDF]
Ganesan S +6 more
europepmc +1 more source
Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris +11 more
wiley +1 more source
ABSTRACT Background Immunotherapy response rates in head and neck squamous cell carcinoma (HNSCC) are limited by multiple factors. Tumor cell‐derived follistatin (FST) has been linked to immunotherapy resistance, but the underlying mechanisms remain poorly understood. This study aimed to investigate the prognostic value of FST and its associations with
Pan Song +6 more
wiley +1 more source

